COVID-19 and the impact on Alzheimer’s disease patients in Spain


  • In Spain, during the COVID-19 lockdown period, neuropsychiatric symptoms in patients with either Alzheimer’s disease (AD) or amnesic mild cognitive impairment (MCI) worsened. 

Why this matters

    These data suggest that more should be done to educate patients and healthcare providers to be better aware of the worsening symptoms and seek medical attention as needed. Stimulation programs should be continued were possible, with reductions in disruption sought.